Flamingo Pharma (UK) Ltd
Registered name: FLAMINGO PHARMA (UK) LTD
Flamingo Pharma (UK) Ltd made £25.5m revenue and £329k profit in the year to 31 Mar 2025. read from filing text
Flamingo Pharma (UK) Ltd’s revenue fell 7% to £25.5m in the year to 31 Mar 2025, with £329k profit and 14 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Harrow; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Harrow, London
- Age
- 12 yrs · since 2014
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The parent undertaking of Flamingo Pharma (UK) Limited is Flamingo Pharmaceuticals Limited, a company incorporated in India and its registered office is at 7/G&1, Corporate Park, Sion Trombay Road, Ch”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Mar 2022 | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 |
|---|---|---|---|---|
| Disclosure | No P&L | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | ||||
| Revenue (turnover) | — | £16.5m | £27.5m | £25.5m |
| Cost of sales | — | £14.4m | £23.3m | £23.4m |
| Gross profit | — | £2m | £4.2m | £2.1m |
| Operating profit | — | £739k | £840k | £491k |
| Profit before tax | — | £677k | £788k | £440k |
| Profit after tax | — | £550k | £590k | £329k |
| Profit (best available) | — | £550k | £590k | £329k |
| Staff costs | — | £848k | £1.3m | £1.7m |
| Employees (average) | 6 | 9 | 12 | 14 |
| Ratios | ||||
| Profit margin | — | 3.3% | 2.1% | 1.3% |
| Gross margin | — | 12.4% | 15.2% | 8.1% |
| Revenue per employee | — | £1.8m | £2.3m | £1.8m |
| Profit per employee | — | £61.1k | £49.2k | £23.5k |
| Growth (year on year) | ||||
| Revenue growth | — | — | ▲66.7% | ▼7.2% |
| Profit growth | — | — | ▲7.3% | ▼44.2% |
| Headcount growth | — | ▲50% | ▲33.3% | ▲16.7% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £16.2k | £93.6k | £136k | £148k |
| Net assets | £1.9m | £2.5m | £3.1m | £3.4m |
| Fixed assets | £445k | £467k | £241k | £401k |
| Current assets | £5.2m | £10.4m | £13.6m | £18.6m |
| Debtors | £1.6m | £3.3m | £4.6m | £6.6m |
| Deferred income | — | £549k | £976k | £498k |
| Source | FullAccounts · bulk data Nov 2023 | FullAccounts · bulk data Nov 2023 | FullAccounts · bulk data Aug 2024 | FullAccounts · bulk data Nov 2025 |
How the business works
- Profit margin
- 1.3%
- Profit ÷ revenue.
- Gross margin
- 8.1%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £1.8m
- Revenue ÷ average employees.
- Profit per employee
- £23.5k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 1.6%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 2%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 26%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲11%
- Now £3.4m
- Cash at bank
- ▲9%
- Now £148k
- Headcount
- ▲17%
- Now 14
- Deferred income
- ▼49%
- Now £498k
- Fixed assets
- ▲66%
- Now £401k
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Similar profitable businesses
- Pharmaceuticals Direct LimitedWholesale of pharmaceutical goods
- Revenue
- £25.2m
- Profit
- £1.3m
- Staff
- 26
- Reliance Medical LtdStoke-on-Trent · Wholesale of pharmaceutical goods
- Revenue
- £24.5m
- Profit
- £783k
- Staff
- 77
- Crest Medical LimitedWarrington · Wholesale of pharmaceutical goods
- Revenue
- £24.3m
- Profit
- £829
- Staff
- 82
- Medi UK LtdWholesale of pharmaceutical goods
- Revenue
- £23.9m
- Profit
- £1.8m
- Staff
- 42
- GN Hearing UK LtdBicester · Wholesale of pharmaceutical goods
- Revenue
- £23.6m
- Profit
- £858k
- Staff
- 49
- Mylife Diabetes Care LtdEscrick · Wholesale of pharmaceutical goods
- Revenue
- £23.5m
- Profit
- £537k
- Staff
- 39
Sources
Latest figures from FullAccounts for the year to 31 Mar 2025 (profit £329k), from the Companies House accounts bulk data published Nov 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.